|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sipponen P and Correa P: Delayed rise in
incidence of gastric cancer in females results in unique sex ratio
(M/F) pattern: Etiologic hypothesis. Gastric Cancer. 5:213–219.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hogan AM, Collins D, Baird AW and Winter
DC: Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol.
307:19–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions, and
gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: A protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
7
|
Nylander-Koski O, Kiviluoto T,
Puolakkainen P, Kivilaakso E and Mustonen H: The effect of nitric
oxide, growth factors, and estrogen on gastric cell migration. J
Surg Res. 143:230–237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohtani M, García A, Rogers AB, Ge Z,
Taylor NS, Xu S, Watanabe K, Marini RP, Whary MT, Wang TC and Fox
JG: Protective role of 17 beta-estradiol against the development of
Helicobacter pylori-induced gastric cancer in INS-GAS mice.
Carcinogenesis. 28:2597–2604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chandanos E and Lagergren J: Oestrogen and
the enigmatic male predominance of gastric cancer. Eur J Cancer.
44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duell EJ, Travier N, Lujan-Barroso L,
Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello
A, Tumino R, Sacerdote C, et al: Menstrual and reproductive
factors, exogenous hormone, use and gastric cancer risk in a cohort
of women from the European Prospective Investigation Into Cancer
and Nutrition. Am J Epidemiol. 172:1384–1393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohtani M, Ge Z, García A, Rogers AB,
Muthupalani S, Taylor NS, Xu S, Watanabe K, Feng Y, Marini RP, et
al: 17 β-estradiol suppresses Helicobacter pylori-induced
gastric pathology in male hypergastrinemic INS-GAS mice.
Carcinogenesis. 32:1244–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sheh A, Ge Z, Parry NM, Muthupalani S,
Rager JE, Raczynski AR, Mobley MW, McCabe AF, Fry RC, Wang TC and
Fox JG: 17β-estradiol and tamoxifen prevent gastric cancer by
modulating leukocyte recruitment and oncogenic pathways in
Helicobacter pylori-infected INS-GAS male mice. Cancer Prev
Res (Phila). 4:1426–1435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simpson ER: Sources of estrogen and their
importance. J Steroid Biochem Mol Biol. 86:225–230. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Labrie F: All sex steroids are made
intracellularly in peripheral tissue by the mechanisms of
intracrinology after menopause. J Steroid Biochem Mol Biol.
145:133–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frycz BA, Murawa D, Wysocki-Borejsza M,
Marciniak R, Murawa P, Drews M and Jagodziński PP: Expression of
17β-hydroxysteroid dehydrogenase type 1 in gastric cancer. Biomed
Pharmacother. 67:651–657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frycz BA, Murawa D, Borejsza-Wysocki M,
Marciniak R, Murawa P, Drews M and Jagodziński PP: Expression of
17β-hydroxysteroid dehydrogenase type 2 is associated with some
clinicopathological features in gastric cancer. Biomed
Pharmacother. 70:24–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frycz BA, Murawa D, Borejsza-Wysocki M,
Wichtowski M, Spychała A, Marciniak R, Murawa P, Drews M and
Jagodziński PP: Transcript level of AKR1C3 is down-regulated in
gastric cancer. Biochem Cell Biol. 94:138–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gan L, He J, Zhang X, Zhang YJ, Yu GZ,
Chen Y, Pan J, Wang JJ and Wang X: Expression profile and
prognostic role of sex hormone receptors in gastric cancer. BMC
Cancer. 12:5662012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian Y, Wan H, Lin Y, Xie X, Li Z and Tan
G: Androgen receptor may be responsible for gender disparity in
gastric cancer. Med Hypotheses. 80:672–674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chomczynski P and Sacchi N: The
single-step method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction: Twenty-something years
on. Nat Protoc. 1:581–585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tellmann G: The E-Method: A highly
accurate technique for gene-expression analysis. Nature methods.
3:i–ii. 2006. View
Article : Google Scholar
|
|
22
|
Hashimoto T, Bazmi HH, Mirnics K, Wu Q,
Sampson AR and Lewis DA: Conserved regional patterns of
GABA-related transcript expression in the neocortex of subjects
with schizophrenia. Am J Psychiatry. 165:479–489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rawłuszko AA, Antoniucci M, Horbacka K,
Lianeri M, Krokowicz P and Jagodziński PP: Reduced expression of
steroid sulfatase in primary colorectal cancer. Biomed
Pharmacother. 67:577–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ruder HJ, Loriaux L and Lipsett MB:
Estrone sulfate: Production rate and metabolism in man. J Clin
Invest. 51:1020–1033. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Labrie F: Extragonadal synthesis of sex
steroids: Intracrinology. Ann Endocrinol (Paris). 64:95–107.
2003.PubMed/NCBI
|
|
26
|
Secky L, Svoboda M, Klameth L, Bajna E,
Hamilton G, Zeillinger R, Jäger W and Thalhammer T: The sulfatase
pathway for estrogen formation: Targets for the treatment and
diagnosis of hormone-associated tumors. J Drug Deliv.
2013:9576052013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chetrite GS, Cortes-Prieto J, Philippe JC,
Wright F and Pasqualini JR: Comparison of estrogen concentrations,
estrone sulfatase and aromatase activities in normal, and in
cancerous, human breast tissue samples. J Steroid Biochem Mol Biol.
72:23–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Utsumi T, Yoshimura N, Takeuchi S, Maruta
M, Maeda K and Harada N: Elevated steroid sulfatase expression in
breast cancers. J Steroid Biochem Mol Biol. 73:141–145. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miyoshi Y, Ando A, Hasegawa S, Ishitobi M,
Taguchi T, Tamaki Y and Noguchi S: High expression of steroid
sulfatase mRNA predicts poor prognosis in patients with estrogen
receptor-positive breast cancer. Clin Cancer Res. 9:2288–2293.
2003.PubMed/NCBI
|
|
30
|
Suzuki T, Miki Y, Nakata T, Shiotsu Y,
Akinaga S, Inoue K, Ishida T, Kimura M, Moriya T and Sasano H:
Steroid sulfatase and estrogen sulfotransferase in normal human
tissue and breast carcinoma. J Steroid Biochem Mol Biol.
86:449–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Poisson Paré D, Song D, Luu-The V, Han B,
Li S, Liu G, Labrie F and Pelletier G: Expression of estrogen
sulfotransferase 1E1 and steroid sulfatase in breast cancer: A
immunohistochemical study. Breast Cancer (Auckl). 3:9–21.
2009.PubMed/NCBI
|
|
32
|
Suzuki M, Ishida H, Shiotsu Y, Nakata T,
Akinaga S, Takashima S, Utsumi T, Saeki T and Harada N: Expression
level of enzymes related to in situ estrogen synthesis and
clinicopathological parameters in breast cancer patients. J Steroid
Biochem Mol Biol. 113:195–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hanamura T, Niwa T, Gohno T, Kurosumi M,
Takei H, Yamaguchi Y, Ito K and Hayashi S: Possible role of the
aromatase-independent steroid metabolism pathways in hormone
responsive primary breast cancers. Breast Cancer Res Treat.
143:69–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khvostova EP, Otpuschennikov AA,
Pustylnyak VO and Gulyaeva LF: Gene expression of androgen
metabolising enzymes in benign and malignant prostatic tissues.
Horm Metab Res. 47:119–124. 2015.PubMed/NCBI
|
|
35
|
Montgomery RB, Mostaghel EA, Vessella R,
Hess DL, Kalhorn TF, Higano CS, True LD and Nelson PS: Maintenance
of intratumoral androgens in metastatic prostate cancer: A
mechanism for castration-resistant tumor growth. Cancer Res.
68:4447–4454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang KH, Ercole CE and Sharifi N:
Androgen metabolism in prostate cancer: From molecular mechanisms
to clinical consequences. Br J Cancer. 111:1249–1254. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saitoh Y, Sasano H, Naganuma H, Ohtani H,
Sasano N, Ohuchi A and Matsuno S: De novo expression of aromatase
in gastric carcinoma. Light and electron microscopic
immunohistochemical and immunoblot study. Pathol Res Pract.
188:53–60. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Izawa M, Inoue M, Osaki M, Ito H, Harada
T, Terakawa N and Ikeguchi M: Cytochrome P450 aromatase gene
(CYP19) expression in gastric cancer. Gastric Cancer. 11:103–110.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ueyama T, Shirasawa N, Numazawa M, Yamada
K, Shelangouski M, Ito T and Tsuruo Y: Gastric parietal cells:
Potent endocrine role in secreting estrogen as a possible regulator
of gastro-hepatic axis. Endocrinology. 143:3162–3170. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ueyama T, Shirasawa N, Ito T and Tsuruo Y:
Estrogen-producing steroidogenic pathways in parietal cells of the
rat gastric mucosa. Life Sci. 74:2327–2337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kobayashi H, Yoshida S, Sun YJ, Shirasawa
N and Naito A: 17β-Estradiol in the systemic circulation derives
mainly from the parietal cells in cholestatic female rats. J
Endocrinol Invest. 39:389–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ozawa M, Takahashi K, Akazawa KH,
Takashima T, Nagata H, Doi H, Hosoya T, Wada Y, Cui Y, Kataoka Y
and Watanabe Y: PET of aromatase in gastric parietal cells using
11C-vorozole. J Nucl Med. 52:1964–1969. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kobayashi H, Yoshida S, Sun YJ, Shirasawa
N and Naito A: Postnatal development of gastric aromatase and
portal venous estradiol-17β levels in male rats. J Endocrinol.
218:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kobayashi H, Yoshida S, Sun YJ, Shirasawa
N and Naito A: Gastric estradiol-17β (E2) and liver ERα correlate
with serum E2 in the cholestatic male rat. J Endocrinol. 219:39–49.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pasqualini JR and Chetrite G: Paradoxical
effect of estradiol: It can block its own bioformation in human
breast cancer cells. J Steroid Biochem Mol Biol. 78:21–24. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pasqualini JR and Chetrite GS: Estradiol
as an anti-aromatase agent in human breast cancer cells. J Steroid
Biochem Mol Biol. 98:12–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Levin ER: Extranuclear steroid receptors
are essential for steroid hormone actions. Annu Rev Med.
66:271–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rahman Ur MS and Cao J: Estrogen receptors
in gastric cancer: Advances and perspectives. World J
Gastroenterol. 22:2475–2482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hayashi SI, Eguchi H, Tanimoto K, Yoshida
T, Omoto Y, Inoue A, Yoshida N and Yamaguchi Y: The expression and
function of estrogen receptor alpha and beta in human breast cancer
and its clinical application. Endocr Relat Cancer. 10:193–202.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shanle EK and Xu W: Selectively targeting
estrogen receptors for cancer treatment. Adv Drug Deliv Rev.
62:1265–1276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xie LQ, Yu JP and Luo HS: Expression of
estrogen receptor beta in human colorectal cancer. World J
Gastroenterol. 10:214–217. 2004.PubMed/NCBI
|
|
52
|
Risbridger GP, Davis ID, Birrell SN and
Tilley WD: Breast and prostate cancer: More similar than different.
Nat Rev Cancer. 10:205–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chandanos E, Rubio CA, Lindblad M, Jia C,
Tsolakis AV, Warner M, Gustafsson JA and Lagergren J: Endogenous
estrogen exposure in relation to distribution of histological type
and estrogen receptors in gastric adenocarcinoma. Gastric Cancer.
11:168–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kameda C, Nakamura M, Tanaka H, Yamasaki
A, Kubo M, Tanaka M, Onishi H and Katano M: Oestrogen
receptor-alpha contributes to the regulation of the hedgehog
signalling pathway in ERalpha-positive gastric cancer. Br J Cancer.
102:738–747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG,
Shen JY and Wang LB: Prognostic role of estrogen receptor alpha and
estrogen receptor beta in gastric cancer. Ann Surg Oncol.
17:2503–2509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Deng H, Huang X, Fan J, Wang L, Xia Q,
Yang X, Wang Z and Liu L: A variant of estrogen receptor-alpha,
ER-alpha36 is expressed in human gastric cancer and is highly
correlated with lymph node metastasis. Oncol Rep. 24:171–176.
2010.PubMed/NCBI
|
|
57
|
Liu S, He L, Wang Z and Wen G: Expression
of sex hormone receptor in gastric cancer with synchronous ovarian
metastasis and its significance. Zhonghua Yi Xue Za Zhi.
94:1861–1865. 2014.(In Chinese). PubMed/NCBI
|
|
58
|
Järvinen TA, Pelto-Huikko M, Holli K and
Isola J: Estrogen receptor beta is coexpressed with ERalpha and PR
and associated with nodal status, grade, and proliferation rate in
breast cancer. Am J Pathol. 156:29–35. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao
Y, McNeal JE and Ho SM: Dynamic regulation of estrogen
receptor-beta expression by DNA methylation during prostate cancer
development and metastasis. Am J Pathol. 164:2003–2012. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang M, Pan JY, Song GR, Chen HB, An LJ
and Qu SX: Altered expression of estrogen receptor alpha and beta
in advanced gastric adenocarcinoma: Correlation with prothymosin
alpha and clinicopathological parameters. Eur J Surg Oncol.
33:195–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ryu WS, Kim JH, Jang YJ, Park SS, Um JW,
Park SH, Kim SJ, Mok YJ and Kim CS: Expression of estrogen
receptors in gastric cancer and their clinical significance. J Surg
Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Matsuyama S, Ohkura Y, Eguchi H, Kobayashi
Y, Akagi K, Uchida K, Nakachi K, Gustafsson JA and Hayashi S:
Estrogen receptor beta is expressed in human stomach
adenocarcinoma. J Cancer Res Clin Oncol. 128:319–324. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Guo JL, Xu CY, Jiang ZN, Dong MJ, Xie SD,
Shen JG, Cao J and Wang LB: Estrogen receptor beta variants mRNA
expressions in gastric cancer tissue samples and association with
clinicopathologic parameters. Hepatogastroenterology. 57:1584–1588.
2010.PubMed/NCBI
|
|
64
|
Zhou J, Teng R, Xu C, Wang Q, Guo J, Xu C,
Li Z, Xie S, Shen J and Wang L: Overexpression of ERα inhibits
proliferation and invasion of MKN28 gastric cancer cells by
suppressing β-catenin. Oncol Rep. 30:1622–1630. 2013.PubMed/NCBI
|
|
65
|
Kominea A, Konstantinopoulos PA, Kapranos
N, Vandoros G, Gkermpesi M, Andricopoulos P, Artelaris S, Savva S,
Varakis I, Sotiropoulou-Bonikou G and Papavassiliou AG: Androgen
receptor (AR) expression is an independent unfavorable prognostic
factor in gastric cancer. J Cancer Res Clin Oncol. 130:253–258.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang BG, Du T, Zang MD, Chang Q, Fan ZY,
Li JF, Yu BQ, Su LP, Li C, Yan C, et al: Androgen receptor promotes
gastric cancer cell migration and invasion via AKT-phosphorylation
dependent upregulation of matrix metalloproteinase 9. Oncotarget.
5:10584–10595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bjerregaard-Olesen C, Ghisari M, Kjeldsen
LS, Wielsøe M and Bonefeld-Jørgensen EC: Estrone sulfate and
dehydroepiandrosterone sulfate: Transactivation of the estrogen and
androgen receptor. Steroids. 105:50–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
McKenna NJ, Lanz RB and O'Malley BW:
Nuclear receptor coregulators: Cellular and molecular biology.
Endocr Rev. 20:321–344. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang W, Song XW, Bu XM, Zhang N and Zhao
CH: PDCD2 and NCoR1 as putative tumor suppressors in gastric
gastrointestinal stromal tumors. Cell Oncol (Dordr). 39:129–137.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kershah SM, Desouki MM, Koterba KL and
Rowan BG: Expression of estrogen receptor coregulators in normal
and malignant human endometrium. Gynecol Oncol. 92:304–313. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang Z, Yamashita H, Toyama T, Sugiura H,
Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S and Iwase H: NCOR1
mRNA is an independent prognostic factor for breast cancer. Cancer
Lett. 237:123–129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gallardo F, Padrón A, Garcia-Carbonell R,
Rius C, González-Perez A, Arumí-Uria M, Iglesias M, Nonell L,
Bellosillo B, Segura S, et al: Cytoplasmic accumulation of NCoR in
malignant melanoma: Consequences of altered gene repression and
prognostic significance. Oncotarget. 6:9284–9294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kashima H, Horiuchi A, Uchikawa J,
Miyamoto T, Suzuki A, Ashida T, Konishi I and Shiozawa T:
Up-regulation of nuclear receptor corepressor (NCoR) in
progestin-induced growth suppression of endometrial hyperplasia and
carcinoma. Anticancer Res. 29:1023–1029. 2009.PubMed/NCBI
|
|
74
|
Boorjian SA, Heemers HV, Frank I, Farmer
SA, Schmidt LJ, Sebo TJ and Tindall DJ: Expression and significance
of androgen receptor coactivators in urothelial carcinoma of the
bladder. Endocr Relat Cancer. 16:123–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Berns EM, van Staveren IL, Klijn JG and
Foekens JA: Predictive value of SRC-1 for tamoxifen response of
recurrent breast cancer. Breast Cancer Res Treat. 48:87–92. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Fleming FJ, Myers E, Kelly G, Crotty TB,
McDermott EW, O'Higgins NJ, Hill AD and Young LS: Expression of
SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast
cancer; a predictive role for SRC-1. J Clin Pathol. 57:1069–1074.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC,
O'Malley BW and Xu J: Disruption of the SRC-1 gene in mice
suppresses breast cancer metastasis without affecting primary tumor
formation. Proc Natl Acad Sci USA. 106:151–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Qin L, Chen X, Wu Y, Feng Z, He T, Wang L,
Liao L and Xu J: Steroid receptor coactivator-1 upregulates
integrin α5 expression to promote breast cancer cell
adhesion and migration. Cancer Res. 71:1742–1751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Xu Y, Hu B, Qin L, Zhao L, Wang Q, Wang Q,
Xu Y and Jiang J: SRC-1 and Twist1 expression positively correlates
with a poor prognosis in human breast cancer. Int J Biol Sci.
10:396–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Qin L, Wu YL, Toneff MJ, Li D, Liao L, Gao
X, Bane FT, Tien JC, Xu Y, Feng Z, et al: NCOA1 Directly Targets
M-CSF1 Expression to Promote Breast Cancer Metastasis. Cancer Res.
74:3477–3488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Qin L, Xu Y, Xu Y, Ma G, Liao L, Wu Y, Li
Y, Wang X, Wang X, Jiang J, et al: NCOA1 promotes angiogenesis in
breast tumors by simultaneously enhancing HIF1α- and AP-1-mediated
VEGFa transcription. Oncotarget. 6:23890–23904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Flågeng MH, Moi LL, Dixon JM, Geisler J,
Lien EA, Miller WR, Lønning PE and Mellgren G: Nuclear receptor
co-activators and HER-2/neu are upregulated in breast cancer
patients during neo-adjuvant treatment with aromatase inhibitors.
Br J Cancer. 101:1253–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tai H, Kubota N and Kato S: Involvement of
nuclear receptor coactivator SRC-1 in estrogen-dependent cell
growth of MCF-7 cells. Biochem Biophys Res Commun. 267:311–316.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Culig Z, Comuzzi B, Steiner H, Bartsch G
and Hobisch A: Expression and function of androgen receptor
coactivators in prostate cancer. J Steroid Biochem Mol Biol.
92:265–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
